Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.42 |
| ▸ | NQO2 | P16083 | 2/20 | 0.42 |
| ▸ | FBP1 | P09467 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9507242 | 1.00 | LMNA (0.49) | LMNAALDH1A1PTGS1PTGS2CYP1A2 | |
| SCHEMBL22389454 | 0.80 | SMN1; SMN2 (0.48) | LMNAALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL8782103 | 0.79 | GRIN2D (0.55) | LMNAALDH1A1CYP1A2MEN1KMT2A | |
| SCHEMBL8782107 | 0.79 | GRIN2D (0.55) | LMNAALDH1A1CYP1A2MEN1KMT2A | |
| SCHEMBL27662796 | 0.79 | LMNA (0.50) | LMNAALDH1A1PTGS1PTGS2CYP1A2 | |
| SCHEMBL25094429 | 0.79 | GRIN2D (0.55) | LMNAALDH1A1CYP1A2MEN1KMT2A | |
| SCHEMBL4834072 | 0.77 | PTGS2 (0.49) | LMNAALDH1A1PTGS1PTGS2CYP1A2 | |
| SCHEMBL2117755 | 0.77 | LMNA (0.53) | LMNAALDH1A1PTGS1PTGS2CYP1A2 | |
| SCHEMBL3975476 | 0.77 | LMNA (0.53) | LMNAALDH1A1PTGS1PTGS2CYP1A2 | |
| SCHEMBL17712792 | 0.77 | LMNA (0.53) | LMNAALDH1A1PTGS1PTGS2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066303-A1 | ARYL TETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF | NIHON NOHYAKU CO., LTD. (JP) | 2025-02-27 | — | — | US | disclosed |
| EP-4458809-A1 | ARYL TETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF | Nihon Nohyaku Co., Ltd. (JP) | 2024-11-06 | — | — | EP | disclosed |
| CN-118696031-A | Aryltetrahydropyridine derivative or salt thereof, pest control agent containing the same, and method for using the same | 日本农药株式会社 | 2024-09-24 | — | — | CN | disclosed |
| WO-2023127806-A1 | ARYL TETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF | 日本農薬株式会社 | 2023-07-06 | — | — | WO | disclosed |
| EP-0314422-B1 | N-PHENYLALKYLBENZAMIDE FUNGICIDES | DOWELANCO (US) | 1993-07-28 | — | — | EP | disclosed |
| US-4957533-A | THIOAMIDES, AMIDINES | ELI LILLY AND COMPANY (US) | 1990-09-18 | — | — | US | disclosed |
| EP-0314422-A2 | N-phenylalkylbenzamide fungicides | DOWELANCO (US) | 1989-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250066303-A1 | ARYL TETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF | TYR, TH, PRXL2A | LMNA 4378/4885ALDH1A1 1569/4885PTGS1 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.